Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Cash from Operations (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Cash from Operations for 2 consecutive years, with 20970000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Cash from Operations rose 6.5% to 20970000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 60380000.0, a 31.37% increase, with the full-year FY2024 number at 59391000.0, up 1.64% from a year prior.
  • Cash from Operations was 20970000.0 for Q4 2023 at LENZ Therapeutics, down from 13088000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 12798000.0 in Q1 2023 to a low of 22429000.0 in Q4 2022.